Matches in Wikidata for { <http://www.wikidata.org/entity/Q91284980> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q91284980 description "2019 թվականի նոյեմբերի 12-ին հրատարակված գիտական հոդված" @default.
- Q91284980 description "article scientifique publié en 2019" @default.
- Q91284980 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91284980 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91284980 description "scientific article published on 12 November 2019" @default.
- Q91284980 description "wetenschappelijk artikel" @default.
- Q91284980 description "наукова стаття, опублікована 12 листопада 2019" @default.
- Q91284980 name "Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer" @default.
- Q91284980 name "Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer" @default.
- Q91284980 type Item @default.
- Q91284980 label "Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer" @default.
- Q91284980 label "Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer" @default.
- Q91284980 prefLabel "Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer" @default.
- Q91284980 prefLabel "Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer" @default.
- Q91284980 P1433 Q91284980-ABA21C6F-3519-4901-B0B6-9902A8026DF0 @default.
- Q91284980 P1476 Q91284980-CCFE6036-865C-413E-A8AB-1E8620855FD1 @default.
- Q91284980 P2093 Q91284980-8A9F0AA4-D775-47DF-8EC0-1C5FFA54EB5A @default.
- Q91284980 P304 Q91284980-0F4B6BAC-F3C1-4ED0-B15C-72DD163BF7EF @default.
- Q91284980 P31 Q91284980-F895102D-8B42-4393-A7E7-98C90B379B85 @default.
- Q91284980 P356 Q91284980-93996647-C2E9-43DF-A347-2B12F803F0D3 @default.
- Q91284980 P433 Q91284980-D3464A16-1CF2-49A8-AA39-E87AE92BD7BA @default.
- Q91284980 P478 Q91284980-1021831D-2DBA-4642-A201-0668E462097F @default.
- Q91284980 P577 Q91284980-6B27B3EF-C15C-4EC2-B165-CE52D3FC155F @default.
- Q91284980 P698 Q91284980-310A0C6C-F6A7-4AEA-A195-6F2402A1A977 @default.
- Q91284980 P356 J.EURURO.2019.10.014 @default.
- Q91284980 P698 31727449 @default.
- Q91284980 P1433 Q15763991 @default.
- Q91284980 P1476 "Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer" @default.
- Q91284980 P2093 "Guillaume Ploussard" @default.
- Q91284980 P304 "393" @default.
- Q91284980 P31 Q13442814 @default.
- Q91284980 P356 "10.1016/J.EURURO.2019.10.014" @default.
- Q91284980 P433 "3" @default.
- Q91284980 P478 "77" @default.
- Q91284980 P577 "2019-11-12T00:00:00Z" @default.
- Q91284980 P698 "31727449" @default.